Chemomab Therapeutics Ltd. CMMB

Latest FY: 2025 Healthcare Biotechnology
Market Price $2.81
Market Cap $1.63B
P/E Ratio 156.11
Quick Peer Compare (Healthcare):
Revenue (FY 2025)
N/A
Full year reported
Net Income ↑35.5% YoY
-$8.99M
Net Margin: N/A
Free Cash Flow ↑27.6% YoY
-$11.13M
FCF Yield: -0.68%
EPS (Diluted) ↓-53.8% YoY
$0.02
Basic: $0.02
Return on Equity Efficiency
-72.9%
ROA: -65.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CMMB)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $-9.5M $0.0M
FY 2018 $-12.7M -33.5% $-14.7M $-15.0M
FY 2019 $-27.1M -114.3% 0.00% $-16.5M $-16.6M -10.7%
FY 2020 $-11.6M +57.2% 0.00% $-12.7M $-12.7M +23.0%
FY 2021 $16.0M $12.7M $-12.5M -7.5% $0.06 0.00% $-12.4M $-12.6M +1.0%
FY 2022 -100.0% $-5.1M $-27.6M -121.6% $0.12 +101.7% 0.00% $-20.4M $-20.4M -62.0%
FY 2023 $-4.4M $-24.2M +12.4% $0.10 -14.9% 0.00% $-23.6M $-23.6M -15.5%
FY 2024 $-2.5M $-13.9M +42.4% $0.04 -62.1% 0.00% $-15.4M $-15.4M +34.8%
FY 2025 $-2.3M $-9.0M +35.5% $0.02 -53.8% 0.00% $-11.1M $-11.1M +27.6%
$

Valuation

Market Price $2.81
Market Cap $1.63B
Enterprise Value $1.62B
P/E Ratio 156.11
P/B Ratio 131.09
FCF Yield -0.68%
Dividend Yield 0.00%
Shares Outstanding 575,381,320
%

Profitability & Margins

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) -72.93%
Return on Assets (ROA) -65.12%
Asset Turnover 0.00x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 9.08
Cash Ratio 5.12
Debt / Equity 0.000
Debt / Assets 0.000
Cash & Equivalents $7.56M
Total Debt N/A
Book Value / Share $0.02
💧

Cash Flow Efficiency

Operating Cash Flow -$11.13M
Capital Expenditures (CapEx) $3.00K
Free Cash Flow -$11.13M
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $0.02
EPS (Basic) $0.02
Dividends / Share N/A
Book Value / Share $0.02
EPS YoY Growth -53.85%
🏛️

Balance Sheet (FY 2025)

Total Assets $13.81M
Total Liabilities $1.48M
Stockholders' Equity $12.33M
Current Assets $13.43M
Current Liabilities $1.48M